Study links drugs for Alzheimer’s disease with reduced risk of heart attack and deathBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f3669 (Published 05 June 2013) Cite this as: BMJ 2013;346:f3669
- Ingrid Torjesen
Patients taking cholinesterase inhibitors for mild to moderate Alzheimer’s disease have been found to have a lower risk of heart attack and death than patients who have never taken the drugs, a Swedish study has found.1
Researchers from Umeå University in Sweden followed 7073 people with Alzheimer’s disease who were on the Swedish Dementia Registry from May 2007 to December 2010. They found that those patients who had been taking cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, had a 36% lower risk of death from any cause than people not taking the drugs: 427 of 5159 (8.3%) who were …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial